Literature DB >> 33819136

The structure of CLEC-2: mechanisms of dimerization and higher-order clustering.

Eleyna M Martin1, Malou Zuidscherwoude1, Luis A Morán1,2, Ying Di1, Angel García2, Steve P Watson1,3.   

Abstract

The platelet C-type lectin-like receptor CLEC-2 drives inflammation-driven venous thrombosis in mouse models of thrombo-inflammatory disease with a minimal effect on hemostasis identifying it as a target for a new class of antiplatelet agent. Here, we discuss how the protein structure and dynamic arrangement of CLEC-2 on the platelet membrane helps the receptor, which has a single YxxL motif (known as a hemITAM), to trigger intracellular signaling. CLEC-2 exists as a monomer and homo-dimer within resting platelets and forms higher-order oligomers following ligand activation, a process that is mediated by the multivalent nature of its ligands and the binding of the tandem SH2 domains of Syk to the phosphorylated hemITAM and concomitantly to PIP2 or PIP3 to localize it to the membrane. We propose that a low level of active Syk is present at the membrane in resting platelets due to phosphorylation by Src family kinases and that clustering of receptors disturbs the equilibrium between kinases and phosphatases, triggering phosphorylation of the CLEC-2 hemITAM and recruitment of Syk. Knowledge of the structure of CLEC-2 and the mechanism of platelet activation has important implications for development of therapeutics.

Entities:  

Keywords:  C-type lectins; CLEC-2; Itam signaling; Syk; platelets; podoplanin

Mesh:

Substances:

Year:  2021        PMID: 33819136     DOI: 10.1080/09537104.2021.1906407

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  4 in total

1.  Clustering extent-dependent differential signaling by CLEC-2 receptors in platelets.

Authors:  Carol Dangelmaier; Hymavathi Reddy Vari; Monica Wright; John C Kostyak; Satya P Kunapuli
Journal:  Res Pract Thromb Haemost       Date:  2022-05-06

2.  CLEC14A was up-regulated in hepatocellular carcinoma and may function as a potential diagnostic biomarker.

Authors:  Lang Yan; Xiang Li; Yunfeng Yuan
Journal:  Clinics (Sao Paulo)       Date:  2022-05-13       Impact factor: 2.898

Review 3.  Thrombosis and Inflammation-A Dynamic Interplay and the Role of Glycosaminoglycans and Activated Protein C.

Authors:  Shrey Kohli; Khurrum Shahzad; Annukka Jouppila; Harry Holthöfer; Berend Isermann; Riitta Lassila
Journal:  Front Cardiovasc Med       Date:  2022-03-31

4.  Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet Agonist.

Authors:  Luis A Morán; Ying Di; Marcin A Sowa; Lidia Hermida-Nogueira; María N Barrachina; Eleyna Martin; Joanne C Clark; Todd H Mize; Johannes A Eble; David Moreira; Alice Y Pollitt; María I Loza; Eduardo Domínguez; Steve P Watson; Ángel García
Journal:  Thromb Haemost       Date:  2022-02-15       Impact factor: 6.681

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.